Combination Therapy for Neovascular Age-Related Macular Degeneration Refractory to Anti–Vascular Endothelial Growth Factor Agents – Corrected Proof

Objective: To examine the outcomes of combination anti–vascular endothelial growth factor (VEGF) and photodynamic therapy (PDT) for the treatment of neovascular age-related macular degeneration (AMD) refractory to anti-VEGF monotherapy.Design: Retrospective, interventional case series.Participants: Twenty-six eyes of 26 patients treated with anti-VEGF monotherapy for neovascular AMD with persistent subretinal or intraretinal fluid after at least 3 anti-VEGF injections in the 7 months before combination treatment.Intervention: Combination anti-VEGF treatment and PDT.Main Outcome Measures: Visual acuity at 1 or 2, 3, and 6 months and central retinal thickness at 1 or 2, 3, and 6 months. Secondary outcome measures were change in number (Read more...)

Full Story →